-
1by Myte, Robin, Gylling, Björn, Häggström, Jenny, Schneede, Jörn, Löfgren-Burström, Anna, Huyghe, Jeroen R., Hallmans, Göran, Meyer, Klaus, Johansson, Ingegerd, Ueland, Per Magne, Palmqvist, Richard, Van Guelpen, Bethany“...) in relation to the risk of molecular subtypes of CRC defined by mutations in the KRAS and BRAF oncogenes...”
Published in PLOS ONE (2018)
Get access
Get access
Article in Journal/Newspaper -
2by Robin Myte, Björn Gylling, Jenny Häggström, Jörn Schneede, Anna Löfgren-Burström, Jeroen R Huyghe, Göran Hallmans, Klaus Meyer, Ingegerd Johansson, Per Magne Ueland, Richard Palmqvist, Bethany Van Guelpen“...) in relation to the risk of molecular subtypes of CRC defined by mutations in the KRAS and BRAF oncogenes...”
Published in PLOS ONE (2018)
Get access
Get access
Article in Journal/Newspaper -
3“... of cytokines in RA patients. Conclusion Proto-oncogene survivin was increased in individuals prior to onset...”
Get access
Article in Journal/Newspaper -
4“... patients. Conclusion: Proto-oncogene survivin was increased in individuals prior to onset of symptoms of RA...”
Get access
Get access
Text -
5by Bokarewa, Maria, Brink, Mikael, Erlandsson, Malin, Rantapää-Dahlqvist, Solbritt“... in RA patients. Conclusion: Proto-oncogene survivin was increased in individuals prior to onset...”
Published in Arthritis Research & Therapy (2014)
Get access
Get access
Article in Journal/Newspaper